KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Emergent BioSolutions (EBS) Current Taxes (2017 - 2018)

Historic Current Taxes for Emergent BioSolutions (EBS) over the last 4 years, with Q4 2018 value amounting to $4.5 million.

Emergent BioSolutions' Current Taxes changed N/A to $4.5 million in Q4 2018 from the same period last year, while for Dec 2018 it was $4.5 million, marking a year-over-year change of. This contributed to the annual value of $4.5 million for FY2018, which is N/A changed from last year.
Latest data reveals that Emergent BioSolutions reported Current Taxes of $4.5 million as of Q4 2018.
Emergent BioSolutions' 5-year Current Taxes high stood at $4.5 million for Q4 2018, and its period low was $164000.0 during Q3 2018.